Ft-Raman data analyzed by multivariate and machine learning as a new methods for detection spectroscopy marker of… Nature.com12:37Cancer Treatment Cancer Global Health

AbbVie agrees $10.1bn deal to buy ImmunoGen pharmaphorum08:51AbbVie Biotech Pharma

STAT Plus: AbbVie buys Immunogen, maker of targeted cancer drugs, for $10 billion STAT08:14AbbVie Biotech Pharma

FDA fast-tracks Genelux’s oncolytic virus-based ovarian cancer therapy Pharmaceutical Technology10:00Cancer FDA Cancer Treatment

EC approves pharmaand’s Rubraca as advanced ovarian cancer maintenance treatment PMLiVE07:40European Commission

Rucaparib receives EC approval for advanced ovarian cancer OncLive12:11European Commission

Mhb-036C by minghui pharmaceutical (shanghai) for epithelial ovarian cancer: Likelihood of… Pharmaceutical Technology21:07Cancer Treatment Cancer Health

Exs-617 by exscientia for epithelial ovarian cancer: Likelihood of Approval Pharmaceutical Technology12:55Cancer Treatment Cancer Health

FDA grants priority review to mirvetuximab soravtansine in FRα+ platinum-Resistant ovarian cancer OncLive18:42Cancer Treatment FDA Cancer

AbbVie going big on ADCs through $10bn ImmunoGen buy BioProcess Insider10:09Cancer Treatment FDA Cancer

Latest News

In the last 8 hours

Your risk of certain type of cancer skyrockets if you work in one of these 7 professions The Mirror03:51

Yesterday

Man fought 'seven-year battle to expose the truth' after his wife's 'avoidable' death from… Mail Online14:52 9-Dec-23

In the last 7 days

Tennis legend Chris Evert, 68, reveals second ovarian cancer diagnosis since 2021 and says she… Mail Online23:11 8-Dec-23

Tennis legend Chris Evert says cancer has returned CBS News23:05 8-Dec-23

Woman's ovarian cancer death was avoidable BBC15:52 8-Dec-23

AbbVie to Acquire ImmunoGen in Deal Valued at $10.1 Billion PharmTech.com11:13 8-Dec-23

AstraZeneca/Merck’s Lynparza combination recommended by NICE for advanced ovarian cancer PMLiVE07:28 8-Dec-23

Regeneron to Share Progress of Novel Combination Therapies in Oncology at ESMO IO GlobeNewswire (Press Release)02:33 7-Dec-23

STAT Plus: Using Pap smears for earlier ovarian cancer detection shows promise in small new… STAT14:06 6-Dec-23

EXS-617 by Exscientia for Epithelial Ovarian Cancer: Likelihood of Approval Pharmaceutical Technology12:55 6-Dec-23

Photoacoustic imaging improves diagnostic accuracy of cancerous ovarian lesions Washington University in St. Louis12:36 6-Dec-23

Novel Doublet Highly Effective in Low-Grade Serous Ovarian Cancer Medpage Today01:32 6-Dec-23

BI-765179 by Boehringer Ingelheim International for Ovarian Cancer: Likelihood of Approval Pharmaceutical Technology21:58 5-Dec-23

AMG-305 by Amgen for Epithelial Ovarian Cancer: Likelihood of Approval Pharmaceutical Technology21:38 5-Dec-23

MHB-088C by Minghui Pharmaceutical (Shanghai) for Epithelial Ovarian Cancer: Likelihood of… Pharmaceutical Technology21:17 5-Dec-23

MHB-088C by Minghui Pharmaceutical (Shanghai) for Metastatic Ovarian Cancer: Likelihood of… Pharmaceutical Technology21:17 5-Dec-23

MHB-036C by Minghui Pharmaceutical (Shanghai) for Epithelial Ovarian Cancer: Likelihood of… Pharmaceutical Technology21:07 5-Dec-23

MHB-036C by Minghui Pharmaceutical (Shanghai) for Metastatic Ovarian Cancer: Likelihood of… Pharmaceutical Technology21:07 5-Dec-23

ALG.APV-527 by Alligator Bioscience for Metastatic Ovarian Cancer: Likelihood of Approval Pharmaceutical Technology20:47 5-Dec-23

FDA Grants Priority Review to Mirvetuximab Soravtansine in FRα+ Platinum-Resistant Ovarian Cancer OncLive18:42 5-Dec-23

Hospital consultant who performed 'routine' surgery to remove a cyst from a nurse, 35, who… Mail Online14:22 5-Dec-23

LB-101 by Centessa Pharmaceuticals for Metastatic Ovarian Cancer: Likelihood of Approval Pharmaceutical Technology12:37 5-Dec-23

MET-4 by Nubiyota for Ovarian Cancer: Likelihood of Approval Pharmaceutical Technology12:27 5-Dec-23

FDA Grants Breakthrough Device Designation to Assay for ACR-368 in Ovarian Cancer OncLive11:24 5-Dec-23

FDA Grants Priority Review of ImmunoGen’s Supplemental Biologics License Application for… Business Wire (Press Release)06:36 5-Dec-23

XL-309 by Exelixis for Metastatic Ovarian Cancer: Likelihood of Approval Pharmaceutical Technology00:53 5-Dec-23

PORT-6 by Portage Biotech for Ovarian Cancer: Likelihood of Approval Pharmaceutical Technology00:02 5-Dec-23

Niraparib by GSK for Ovarian Cancer: Likelihood of Approval Pharmaceutical Technology22:10 4-Dec-23

Etrumadenant by Arcus Biosciences for Metastatic Ovarian Cancer: Likelihood of Approval Pharmaceutical Technology20:58 4-Dec-23

Cancer victim may have survived with correct op BBC16:16 4-Dec-23

Ovarian Cancer Research Outlines the Role of ADCs, PARP Inhibitors, and Surgery OncLive10:21 4-Dec-23

The impact of Natural and Surgical Menopause in the Indian Population Your Say Blog09:14 4-Dec-23

AbbVie acquires biotech ImmunoGen Pharmaceutical Field04:51 4-Dec-23

In the last month

Immune-Targeted Therapy Continues to Fall Short in Ovarian Cancer OncLive10:16 1-Dec-23

AbbVie going big on ADCs through $10bn ImmunoGen buy BioProcess Insider10:09 1-Dec-23

AbbVie agrees $10 billion oncology acquisition European Pharmaceutical Review06:23 1-Dec-23

AbbVie to acquire ImmunoGen for approximately $10.1bn Pharmafile06:04 1-Dec-23

AbbVie diversifies oncology portfolio with $10.1 bn ImmunoGen acquisition Pharmaceutical Technology13:23 30-Nov-23

AbbVie to Acquire ImmunoGen for $10.1B, Expanding Cancer Franchise Genetic Engineering and Biotechnology News12:39 30-Nov-23

Study Highlights BMP7 As a Potential Therapeutic Target for Ovarian Cancer American Journal of Managed Care12:34 30-Nov-23

AbbVie joins ADC dealmaking with $10B ImmunoGen buyout BioPharma Dive12:30 30-Nov-23

AbbVie agrees $10.1bn deal to buy ImmunoGen pharmaphorum08:51 30-Nov-23

Pharmaceutical company AbbVie buying ImmunoGen in $10.1 billion deal Mail Online08:22 30-Nov-23

STAT Plus: AbbVie buys Immunogen, maker of targeted cancer drugs, for $10 billion STAT08:14 30-Nov-23

AbbVie signs $10.1 bln deal to buy cancer drugmaker ImmunoGen Reuters07:53 30-Nov-23

Novel DNA vaccine Elenagen, in combination with a proven chemotherapy, demonstrates promising… PR Newswire (Press Release)06:06 30-Nov-23

FDA fast-tracks Genelux’s oncolytic virus-based ovarian cancer therapy Pharmaceutical Technology10:00 27-Nov-23

Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technology PR Newswire (Press Release)08:30 27-Nov-23

FT-Raman data analyzed by multivariate and machine learning as a new methods for detection spectroscopy marker of… Nature.com12:37 26-Nov-23

EC approves first-line ovarian cancer treatment European Pharmaceutical Review09:55 22-Nov-23

Simple blood test for ovarian cancer on horizon Study Finds19:47 21-Nov-23

EC approves pharmaand’s Rubraca as advanced ovarian cancer maintenance treatment PMLiVE07:40 21-Nov-23

Rucaparib Receives EC Approval for Advanced Ovarian Cancer OncLive12:11 20-Nov-23

AI could predict ovarian cancer treatment outcome Knowridge Science Report06:19 20-Nov-23

Cytomegalovirus Common in Patients With Ovarian Cancer, May Contribute to Cognitive Impairment American Journal of Managed Care10:35 19-Nov-23

Ovarian Cancer: New Biological Markers Found That May Predict Which Patients Won't Respond to Chemotherapy OncLive08:30 19-Nov-23

ADPA-2M4CD8 by Adaptimmune Therapeutics for Ovarian Cancer: Likelihood of Approval Pharmaceutical Technology20:49 18-Nov-23

Tusamitamab ravtansine by Sanofi for Epithelial Ovarian Cancer: Likelihood of Approval Pharmaceutical Technology14:22 18-Nov-23

Casey Mclntyre: How this cancer patient freed others from $16 million medical debt The News International12:57 18-Nov-23

New York mom who died from ovarian cancer erases $17 million in medical debt for other patients … Mail Online09:43 18-Nov-23

TSC-204-C0702 by TScan Therapeutics for Metastatic Ovarian Cancer: Likelihood of Approval Pharmaceutical Technology23:27 17-Nov-23

BNT-325 by Duality Biologics (Shanghai) for Ovarian Cancer: Likelihood of Approval Pharmaceutical Technology23:17 17-Nov-23

TSC-204 HLA-A*02:01 by TScan Therapeutics for Metastatic Ovarian Cancer: Likelihood of Approval Pharmaceutical Technology23:07 17-Nov-23

Sacituzumab tirumotecan by Merck for Epithelial Ovarian Cancer: Likelihood of Approval Pharmaceutical Technology22:46 17-Nov-23

US woman's dying wish erases $16m in medical debt BBC22:16 17-Nov-23

One ovarian cancer fix: removing the fallopian tubes Newswise (Press Release)19:33 17-Nov-23

Raludotatug Deruxtecan Elicits Early Efficacy and Safety in Platinum-Resistant Ovarian Cancer OncLive13:26 17-Nov-23

Gradalis wins $9.9m grant to fund Phase II trial for bi-shRNA therapy Pharmaceutical Technology11:11 17-Nov-23

Olaparib Does Not Improve OS vs Chemo in Recurrent Platinum-Sensitive Ovarian Cancer American Journal of Managed Care09:25 17-Nov-23

Aussie rock singer and popular The Voice contestant Virginia Lillye fights stage three ovarian… Mail Online08:31 17-Nov-23

Tired of waiting, this woman took action and found her cancer diagnosis on her own Global News06:15 17-Nov-23

BT-7480 by Bicycle Therapeutics for Ovarian Cancer: Likelihood of Approval Pharmaceutical Technology23:48 16-Nov-23

EVT-801 by Kazia Therapeutics for Ovarian Cancer: Likelihood of Approval Pharmaceutical Technology23:27 16-Nov-23

Olaparib With/Without Cediranib Does Not Improve OS Vs Chemo in Recurrent Platinum-Sensitive Ovarian Cancer OncLive15:15 16-Nov-23

On Target Laboratories Secures $30 Million for Commercialization of CYTALUX® (pafolacianine)… PR Newswire (Press Release)08:01 16-Nov-23

Ovarian cancer: Artificial intelligence predicts therapy responses ecancer12:39 15-Nov-23

Comedian Janey Godley 'happy' as she shares update on her terminal ovarian cancer The Mirror11:55 15-Nov-23

AI Accurately Predicts Therapy Outcomes in Most Patients With Ovarian Cancer American Journal of Managed Care10:55 15-Nov-23

Scottish comedian Janey Godley 'happy' after 'clear scan' signals ovarian cancer 'at bay' The Scotsman09:17 15-Nov-23

Mother, 38, announces her own death from ovarian cancer in heartbreaking pre-written Instagram… Mail Online07:13 15-Nov-23

Mum posts message from beyond the grave announcing her own death saying 'I'm so sorry' The Mirror19:29 14-Nov-23

Artificial intelligence predicts ovarian cancer therapy responses Science Blog (Weblog)11:20 13-Nov-23

Improving ovarian cancer outcomes with artificial intelligence Drug Target Review10:56 13-Nov-23

New Healthcare Professional Component of Let’s Talk About LGSOC to Raise Awareness of Low-Grade … Business Wire (Press Release)07:05 13-Nov-23

Next-generation ovarian cancer therapy: Engineered Vδ2 T cells show promise in preclinical trials News-Medical.Net05:03 13-Nov-23

Europe Ovarian Cancer Market Size, Share and Forecast Report 2023-2030 Industry Today13:44 10-Nov-23

Bispecific Antibody Shows Clinical Activity in Recurrent Ovarian Cancer Medpage Today01:05 10-Nov-23

Markman Underscores Unanswered Questions in Ovarian Cancer Management OncLive17:00 9-Nov-23

Survey Finds Gaps in Care for Patients With Slow-Growing Ovarian Cancer American Journal of Managed Care16:40 9-Nov-23

view more headlines

10 Dec 03:51

Ovarian Cancer

Latest News

Cancer Top Stories

Health Top Stories

Lifestyle Top Stories